PEComa is a rare mesenchymal tumor. According to the existing relevant reports, it is mostly found in many organs such as kidney, lung and uterus. Solid pseudopapillary neoplasm are rare, with the majority of described cases originating in the pancreas[5].PEComa rarely occurs in the gastrointestinal tract, and most of them are benign or low malignant tumors, with less distant metastasis; Gastrointestinal PEComa is usually not accompanied by characteristic clinical symptoms. Discomfort symptoms such as abdominal mass, bloody stool, abdominal pain and intestinal obstruction can appear according to the size and location of the tumor. Sometimes patients will not have any symptoms, which can be found in routine physical examination; Before surgical resection, PEComa can’t be diagnosed only by clinical manifestations and imaging examination, because PEComa has no specificity in both. On CT, the tumor only shows clear boundary, uneven or uniform enhancement[6]. On magnetic resonance imaging (MRI), the lesions show bright on T1-weighted images and dark on fat- suppressed images[7]. Angiomyolipoma (AML) is the most common PEComa type. AML is categorized into two types: classic AML and epithelioid AML. Epithelioid AML is more common than classic AML in abdominal tumors or lung malignant metastases[8];
In the pathological examination, the PEComa tumor cells are arranged in a sheet or nest shape. There is a significant fibrous vascular network between the cell nests, and some tumor cells are arranged radially around the hyaline vascular wall, which has diagnostic value[9]; In the study of He, S. et al.[10], the pathological manifestations of solid pseudopapillary neoplasm of ovary are as follows: The tumor is composed of sheets and nests of cells that appear to be polygonal, interrupted by a delicate fibrous septa and capillary network, and focally by broad hyalinized bands. Therefore, the pathological examination is not specific in distinguishing PEComa from solid pseudopapillary neoplasm of ovary. In immunohistochemical detection, PEComa is mainly expressed as the co-expression of melanocytic (HMB-45, Melan-A) and smooth muscle (actin, desmin) markers to avoid misdiagnosis as leiomyosarcoma and other lesions[11]; The immunohistochemical manifestations of this patient were EMA, HMB45, TFE-3, CyclinD1,β- Catenin was positive; The diagnostic criteria of malignant PEComa recommended in the study of Folpe et al[3].It must meet the following two or more criteria: tumor size>5 cm, infiltrative growth pattern, high nuclear grade, necrosis, and mitotic activity>1/50 HPF and subsequent aggressive clinical behavior.
At present, surgical resection of diseased tumors is the first choice for PEComa. However, incomplete tumor resection may cause local recurrence or accelerate distant metastasis. For some patients with local recurrence and distant metastasis, it is necessary to choose chemotherapy as adjuvant treatment after operation{Wejman, 2015 #8}[12]. The patients reported in this paper were given four cycles of chemotherapy with paclitaxel and platinum after first surgery.And a treatment regimen after second surgery, which is immunotherapy (Tislelizumab) combined with targeted therapy (Apatinib). But now the patient has died of complications.
In general, malignant gastrointestinal PEComa is a rare tumor. There is no obvious specificity in clinical manifestations andpathological examination, and it is very easy to be misdiagnosed as other diseases with similar manifestations. Therefore, immunohistochemical detection plays an important role in the diagnosis of PEComa; The final diagnosis of this patient is mainly based on immunohistochemical detection, in which the expression of HMB-45 and TFE-3 plays a key role.Although the above two diseases are rare and less primary in the gastrointestinal tract, they should be carefully distinguished to avoid misdiagnosis.